MedTrace Logo

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit

NCT04528043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2020-08-27

No results posted yet for this study

Summary

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

Conditions

  • Critically Ill
  • Enterobacteriaceae Infections
  • Antibiotic Resistant Infection

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2019-01-10
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04528043 on ClinicalTrials.gov